טוען...
A Novel System for Estimating Residual Disease and Pathologic Response to Neoadjuvant Treatment of Prostate Cancer
BACKGROUND: Pathologic variables that characterize response of prostate carcinoma to current neoadjuvant therapy have not been characterized in detail. This study reports (1) the histological features of prostate cancer treated with abiraterone and enzalutamide and inter-pathologist variance in iden...
שמור ב:
| הוצא לאור ב: | Prostate |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4988926/ https://ncbi.nlm.nih.gov/pubmed/27273062 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.23215 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|